Helping East African children and young adults with type 1 diabetes keep blood sugar in range
Diabetes in African Youth: Improving Glucose Time-In-Range
This project sees if giving unblinded flash continuous glucose monitors to East African youth aged 4–26 helps them spend more time with blood sugar between 70–180 mg/dL than fingerstick monitoring.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Minnesota NIH-funded |
| Lab location | 1 site (Minneapolis, United States) |
| Project ID | NIH-11506265 on NIH RePORTER |
What this research studies
If you join, you'll get the same monthly diabetes education provided to all participants. For six months, half of participants (90) will use an unblinded flash CGM that shows glucose in real time, while the other half (90) will check blood sugar by fingerstick at least three times daily and wear a blinded CGM for outcome measurement. People are randomly assigned to the two groups and the study will track time-in-range and episodes of low and high blood sugar. The team will also compare costs to see if flash CGM is affordable and practical in low-resource East African settings.
Who could benefit from this research
Good fit: Children and young adults aged 4–26 with type 1 diabetes receiving care at participating clinics in East Africa would be the ideal candidates.
Not a fit: People without type 1 diabetes, those outside the 4–26 age range, or those unable to use CGM devices or perform fingerstick monitoring are unlikely to benefit from participating.
Why it matters
Potential benefit: If successful, this could help East African children and young adults with type 1 diabetes have safer blood sugar levels and fewer dangerous low or high episodes.
How similar studies have performed: Continuous glucose monitoring has improved time-in-range in many studies in high-income countries, but using flash CGM in low-resource East African youth is less well-studied.
Where this research is happening
Minneapolis, United States
- University of Minnesota — Minneapolis, United States (Active)
Researchers
- Principal investigator: Moran, Antoinette M. — University of Minnesota
- Study coordinator: Moran, Antoinette M.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.